Ethical Considerations in the Treatment of Uterine Cancer

Ethical Considerations in the Treatment of Uterine Cancer

Introduction

The part of reproductive system of a woman is called the uterus, which is a hollow organ in the pelvis. Uterus has three major parts of top, middles, and bottom, where the top part (fundus) is shaped like a dome extending the ovaries from the Fallopian tubes that are at the top of the uterus; the middle part is corpus that is the body of the uterus, it is the place where growth of the baby takes place; and the bottom is the cervix, which a narrow lower part of the uterus, it is a passage to the vagina. There are two layers of tissue of the uterus that is inner layer and the outer layers. The inner layer or the inner lining of the uterus is the endometrium. While the outer layer of the tissue is the myometrium (Amant, Moerman, Neven, et al., 2005).

The cancer in uterus nearly starts in the endometrium. They are known as endometrial carcinomas, whereas the cancer that starts in the muscle layer of the uterus belongs to the cancer group known as sarcomas. It is reported in the American Cancer Society that in 2012, in United States uterus cancer of both uterine sarcomas and endometrial cancer are estimated to be around 47,130 cases of uterus cancer and estimated deaths caused due to uterus cancer are around 8,010. The United States is reported to be having to be reported of endometrium cancer in the reproductive female organs, and the chance of females having endometrium cancer in her life span is nearly one in thirty-eight (American Cancer Society, 2012).

Discussion

Analysis Utilizing Ethical Principles

It is made obligatory by the International Covenant on Economic, Social, and Cultural Rights for participating nations to make the easy availability of treatments of every pain within their borders. It is the ethical obligations of nurses and doctors to make certain the treatment of pain is given to the patient or withheld by informing the patient completely. It is imperative of providing the patient with the upfront information pertaining to any serious risk or side effects of the treatment that they are being undertaken with. Risks or harms that are normal or acceptable to the medical professional may not be acceptable to the patient (Lohman, Schleifer, & Amon, 2010). Patients that are well informed, when are communicating with their health care professionals for their treatments are likely to attain optimal treatment for their pain. The health care professionals should not force patients to undertake treatment which they are not willing to take to finding the treatment risky or harmful (Blinderman, 2012).

Patients that are incurably ill may not be willing to take the decision on their own; rather they leave the pain management decision on their health care providers. It the right of the patient to participate in taking pain management decision; however, it is not an obligation, while lower involvement of patient may leads to lesser management of pain, but their ...